These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16424403)

  • 1. COPD, inflammation and its modulation by phosphodiesterase 4 inhibitors: time to look beyond the FEV1.
    Celli B
    Chest; 2006 Jan; 129(1):5-6. PubMed ID: 16424403
    [No Abstract]   [Full Text] [Related]  

  • 2. Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4.
    Rennard SI; Schachter N; Strek M; Rickard K; Amit O
    Chest; 2006 Jan; 129(1):56-66. PubMed ID: 16424413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase 4 inhibitors: antiinflammatory therapy for chronic obstructive pulmonary disease at last?
    Kerstjens HA; Timens W
    Am J Respir Crit Care Med; 2003 Oct; 168(8):914-5. PubMed ID: 14555456
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease.
    Gamble E; Grootendorst DC; Brightling CE; Troy S; Qiu Y; Zhu J; Parker D; Matin D; Majumdar S; Vignola AM; Kroegel C; Morell F; Hansel TT; Rennard SI; Compton C; Amit O; Tat T; Edelson J; Pavord ID; Rabe KF; Barnes NC; Jeffery PK
    Am J Respir Crit Care Med; 2003 Oct; 168(8):976-82. PubMed ID: 12816740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases].
    Xia XD; Dai YR; Xu ZJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan; 27(1):57-9. PubMed ID: 14989829
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective phosphodiesterase-4 inhibitors in chronic obstructive lung disease.
    Soto FJ; Hanania NA
    Curr Opin Pulm Med; 2005 Mar; 11(2):129-34. PubMed ID: 15699784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selective phosphodiesterase-4 (PDE-4) inhibitors in COPD].
    Tatlicioğlu T
    Tuberk Toraks; 2008; 56(4):472-84. PubMed ID: 19123088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilomilast.
    Schachter EN
    Drugs Today (Barc); 2006 Apr; 42(4):237-47. PubMed ID: 16703120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease.
    Giembycz MA
    Br J Clin Pharmacol; 2006 Aug; 62(2):138-52. PubMed ID: 16842388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-alpha production in whole blood from COPD patients.
    Ouagued M; Martin-Chouly CA; Brinchault G; Leportier-Comoy C; Depincé A; Bertrand C; Lagente V; Belleguic C; Pruniaux MP
    Pulm Pharmacol Ther; 2005; 18(1):49-54. PubMed ID: 15607127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease, inflammation and PDE4 inhibitors.
    Halpin DM
    Br J Hosp Med (Lond); 2006 Jul; 67(7):370-4. PubMed ID: 16884152
    [No Abstract]   [Full Text] [Related]  

  • 13. [Selective phosphodiesterase 4 inhibition. Controlling inflammation--also in patients with COPD].
    MMW Fortschr Med; 2004 Apr; 146(18):59. PubMed ID: 15366479
    [No Abstract]   [Full Text] [Related]  

  • 14. Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study.
    Compton CH; Gubb J; Nieman R; Edelson J; Amit O; Bakst A; Ayres JG; Creemers JP; Schultze-Werninghaus G; Brambilla C; Barnes NC;
    Lancet; 2001 Jul; 358(9278):265-70. PubMed ID: 11498212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase-4: selective and dual-specificity inhibitors for the therapy of chronic obstructive pulmonary disease.
    Giembycz MA
    Proc Am Thorac Soc; 2005; 2(4):326-33; discussion 340-1. PubMed ID: 16267357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilomilast: orally active selective phosphodiesterase-4 inhibitor for treatment of chronic obstructive pulmonary disease.
    Martina SD; Ismail MS; Vesta KS
    Ann Pharmacother; 2006 Oct; 40(10):1822-8. PubMed ID: 16985092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammatory lung and systemic disease].
    Med Monatsschr Pharm; 2005 Jul; 28(7):254-5. PubMed ID: 16038131
    [No Abstract]   [Full Text] [Related]  

  • 18. PDE4 inhibitors in COPD--a more selective approach to treatment.
    Vignola AM
    Respir Med; 2004 Jun; 98(6):495-503. PubMed ID: 15191033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase-4 inhibitors as a novel approach for the treatment of respiratory disease: cilomilast.
    Kroegel C; Foerster M
    Expert Opin Investig Drugs; 2007 Jan; 16(1):109-24. PubMed ID: 17155857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD).
    Grootendorst DC; Gauw SA; Benschop N; Sterk PJ; Hiemstra PS; Rabe KF
    Pulm Pharmacol Ther; 2003; 16(6):341-7. PubMed ID: 14580925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.